Good crew it's cool

lamictal 100 mg The FDA approval process has taken over a decade amid concerns of collateral harm should polidocanol enter the user’s bloodstream. Despite the long process, BTG hadn’t been expecting the FDA’s decision until the first half of next year. The London-based pharm-co has previously projected that global sales of Varithena could reach $500 million a year.